Big-money moves in the US on 23/02/01 (Wed)

Insider buys: 175 trades
Insider sales: 427 trades
Congress trades: 0 trades

Notable trades of the day

No trade stood out on this day.

Trades disclosed this day

Abdiel Capital Management10% Owner
BuyAppian
Buy
Appian
APPN
$1.2M
30,000 sh
$1.2M
Filed 23/02/01
Traded 23/01/31
Abdiel Qualified Master Fund10% Owner
BuyAppian
Buy
Appian
APPN
$1.2M
30,000 sh
$1.2M
Filed 23/02/01
Traded 23/01/31
Abdiel Capital10% Owner
BuyAppian
Buy
Appian
APPN
$1.2M
30,000 sh
$1.2M
Filed 23/02/01
Traded 23/01/31
Abdiel Capital Advisors10% Owner
BuyAppian
Buy
Appian
APPN
$1.2M
30,000 sh
$1.2M
Filed 23/02/01
Traded 23/01/31
Colin T. Moran10% Owner
BuyAppian
Buy
Appian
APPN
$1.2M
30,000 sh
$1.2M
Filed 23/02/01
Traded 23/01/31
Abdiel Partners10% Owner
BuyAppian
Buy
Appian
APPN
$1.2M
30,000 sh
$1.2M
Filed 23/02/01
Traded 23/01/31
Column Group III10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$883.7K
176,730 sh
$883.7K
Filed 23/02/01
Traded 23/01/31
Column Group IV GP10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$883.7K
176,730 sh
$883.7K
Filed 23/02/01
Traded 23/01/31
Column Group GP10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$883.7K
176,730 sh
$883.7K
Filed 23/02/01
Traded 23/01/31
Column Group Iii-A10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$883.7K
176,730 sh
$883.7K
Filed 23/02/01
Traded 23/01/31
TCG IV GP10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$883.7K
176,730 sh
$883.7K
Filed 23/02/01
Traded 23/01/31
Column Group IV-A10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$883.7K
176,730 sh
$883.7K
Filed 23/02/01
Traded 23/01/31
Column Group Opportunity III10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$883.7K
176,730 sh
$883.7K
Filed 23/02/01
Traded 23/01/31
Column Group Opportunity III GP10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$883.7K
176,730 sh
$883.7K
Filed 23/02/01
Traded 23/01/31
Column Group IV10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$883.7K
176,730 sh
$883.7K
Filed 23/02/01
Traded 23/01/31
TCG Opportunity III GP10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$883.7K
176,730 sh
$883.7K
Filed 23/02/01
Traded 23/01/31
Tim Kutzkey10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$883.7K
176,730 sh
$883.7K
Filed 23/02/01
Traded 23/01/31
Column Group II GP10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$883.7K
176,730 sh
$883.7K
Filed 23/02/01
Traded 23/01/31
Column Group Management10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$883.7K
176,730 sh
$883.7K
Filed 23/02/01
Traded 23/01/31
Ponoi Capital II10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$883.7K
176,730 sh
$883.7K
Filed 23/02/01
Traded 23/01/31
Ponoi Management10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$883.7K
176,730 sh
$883.7K
Filed 23/02/01
Traded 23/01/31
Ponoi Capital10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$883.7K
176,730 sh
$883.7K
Filed 23/02/01
Traded 23/01/31
Peter Svennilson10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$883.7K
176,730 sh
$883.7K
Filed 23/02/01
Traded 23/01/31
Ponoi II Management10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$883.7K
176,730 sh
$883.7K
Filed 23/02/01
Traded 23/01/31
Column Group II10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$883.7K
176,730 sh
$883.7K
Filed 23/02/01
Traded 23/01/31
Abdiel Partners10% Owner
BuyAppian
Buy
Appian
APPN
$819.5K
20,028 sh
$819.5K
Filed 23/02/01
Traded 23/01/30
Abdiel Capital10% Owner
BuyAppian
Buy
Appian
APPN
$819.5K
20,028 sh
$819.5K
Filed 23/02/01
Traded 23/01/30
Abdiel Qualified Master Fund10% Owner
BuyAppian
Buy
Appian
APPN
$819.5K
20,028 sh
$819.5K
Filed 23/02/01
Traded 23/01/30
Abdiel Capital Advisors10% Owner
BuyAppian
Buy
Appian
APPN
$819.5K
20,028 sh
$819.5K
Filed 23/02/01
Traded 23/01/30
Colin T. Moran10% Owner
BuyAppian
Buy
Appian
APPN
$819.5K
20,028 sh
$819.5K
Filed 23/02/01
Traded 23/01/30
Abdiel Capital Management10% Owner
BuyAppian
Buy
Appian
APPN
$819.5K
20,028 sh
$819.5K
Filed 23/02/01
Traded 23/01/30
Abdiel Capital10% Owner
BuyAppian
Buy
Appian
APPN
$773.3K
18,752 sh
$773.3K
Filed 23/02/01
Traded 23/01/30
Abdiel Capital Advisors10% Owner
BuyAppian
Buy
Appian
APPN
$773.3K
18,752 sh
$773.3K
Filed 23/02/01
Traded 23/01/30
Abdiel Capital Management10% Owner
BuyAppian
Buy
Appian
APPN
$773.3K
18,752 sh
$773.3K
Filed 23/02/01
Traded 23/01/30
Colin T. Moran10% Owner
BuyAppian
Buy
Appian
APPN
$773.3K
18,752 sh
$773.3K
Filed 23/02/01
Traded 23/01/30
Abdiel Partners10% Owner
BuyAppian
Buy
Appian
APPN
$773.3K
18,752 sh
$773.3K
Filed 23/02/01
Traded 23/01/30
Abdiel Qualified Master Fund10% Owner
BuyAppian
Buy
Appian
APPN
$773.3K
18,752 sh
$773.3K
Filed 23/02/01
Traded 23/01/30
Abdiel Capital Management10% Owner
BuyAppian
Buy
Appian
APPN
$511.3K
12,367 sh
$511.3K
Filed 23/02/01
Traded 23/02/01
Abdiel Capital Advisors10% Owner
BuyAppian
Buy
Appian
APPN
$511.3K
12,367 sh
$511.3K
Filed 23/02/01
Traded 23/02/01
Abdiel Capital10% Owner
BuyAppian
Buy
Appian
APPN
$511.3K
12,367 sh
$511.3K
Filed 23/02/01
Traded 23/02/01
Abdiel Qualified Master Fund10% Owner
BuyAppian
Buy
Appian
APPN
$511.3K
12,367 sh
$511.3K
Filed 23/02/01
Traded 23/02/01
Abdiel Partners10% Owner
BuyAppian
Buy
Appian
APPN
$511.3K
12,367 sh
$511.3K
Filed 23/02/01
Traded 23/02/01
Colin T. Moran10% Owner
BuyAppian
Buy
Appian
APPN
$511.3K
12,367 sh
$511.3K
Filed 23/02/01
Traded 23/02/01
Shuxiang Zhang10% Owner
BuyTD Holdings
Buy
TD Holdings
GLG
$12.1M
10,000,000 sh
$12.1M
Filed 23/02/01
Traded 23/01/30
Column GroupDirector
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$883.7K
176,730 sh
$883.7K
Filed 23/02/01
Traded 23/01/31
Column GroupDirector
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$883.7K
176,730 sh
$883.7K
Filed 23/02/01
Traded 23/01/31
Column GroupDirector
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$883.7K
176,730 sh
$883.7K
Filed 23/02/01
Traded 23/01/31
David V. GoeddelDirector
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$883.7K
176,730 sh
$883.7K
Filed 23/02/01
Traded 23/01/31
Sengal SelassieChairman and CEO
BuyBrightwood Capital Corp I
Buy
Brightwood Capital Corp I
$500K
50,505 sh
$500K
Filed 23/02/01
Traded 23/01/30
Column Group Opportunity III GP10% Owner
BuyNGM Biopharmaceuticals
Buy
NGM Biopharmaceuticals
NGM
$37.7K
7,542 sh
$37.7K
Filed 23/02/01
Traded 23/01/30